Rahul Shah bullish on pharma, sees Solar Pharma and Aurobindo as key large-cap performs
Talking to ET Now, market professional Rahul Shah from MOFSL mentioned that Web page Industries stands out as one of many strongest restoration tales inside the shopper area. He highlighted bettering development momentum and constructive administration commentary, stating that “robust efficiency, upbeat on the gross sales half, 11% quarter-on-quarter development, and we imagine that after a very long time we’ve got seen this sort of development coming again in Web page.” He additionally famous that earnings estimates have been revised upward and that the corporate’s product enlargement by means of digital platforms and retail channels is supporting visibility. In response to him, Web page Industries gives uncommon double-digit development visibility in a unstable market and stays fairly valued given its long-term development outlook.
On different shopper names similar to Jerk off and Honasa, Shah adopted a extra cautious stance. He mentioned Jerk off was largely according to expectations and whereas the numbers had been secure, “I really feel that there’s restricted upside on the inventory,” indicating that main re-rating potential could also be capped within the close to time period. Honasa too was seen as largely aligned with expectations with out robust instant triggers for upside.
On broader consumption technique, Shah prompt a balanced portfolio strategy combining choose FMCG names with premium consumption performs. He emphasised Marico as a constant performer within the FMCG area, stating that it continues to face out because of market share power, product launches, and earnings sustainability. Together with Web page Industries, he sees FMCG leaders like Marico as key anchors for taking part in the consumption theme within the present market setting.
Within the insurance coverage area, Shah reiterated the significance of sustaining sector allocation in portfolios. Whereas acknowledging robust numbers from LIC, together with development in worth of latest enterprise margins and annual premium equal, he expressed a choice for Max Monetary Companies inside the area. He highlighted robust margins, sturdy development, and increasing distribution channels past banks, noting that “Max stays our most well-liked guess and we see 20% upside in it.” On the similar time, he indicated that LIC might act as a rerating candidate given bettering sentiment and market positioning.
On the pharma sector, Shah noticed that the area continues to outperform broader markets, supported by world uncertainty and defensive positioning. He famous that the Nifty Pharma index is at a 52-week excessive and highlighted robust efficiency from Solar Pharma and Aurobindo Pharma. Whereas acknowledging that Cipla and Dr Reddy’s delivered weaker outcomes, he maintained a constructive outlook on large-cap pharma, suggesting that Solar Pharma stays a key inventory to observe, particularly after its earnings, whereas Aurobindo Pharma additionally appears to be like engaging after assembly road expectations.
General, the market narrative continues to shift in the direction of selective consumption restoration, regular pharma power, and insurance-driven defensive development. With earnings visibility diverging throughout corporations, buyers are more and more specializing in stock-specific alternatives slightly than broad sector bets.
